Sutter Health Plus
Ozempic (0.25 or 0.5 MG/DOSE) (semaglutide)
Hormones : Drugs for Diabetes
  • ST Required

  • For FAX form click HERE
    Our electronic prior authorization (ePA) process is the preferred method for submitting pharmacy prior authorization requests. Creating an account is free, easy and helps patients get their medications sooner. You can complete the process through your current electronic health record/electronic medical record (EHR/EMR) system or by using one of these ePA sites:
     Log in to Surescripts
     Log in to CoverMyMeds; For details on drug coverage click  HERE;
  • Quantity Limit: 35 grams per 30 day(s).
  • ST_APPLIES
  • ST_APPLIES
  • Narcolepsy Type 1:
    Age Requirement: >= 18
    Duration: 1 plan year
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Neurologist;Sleep Disorders Specialist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year

    Narcolepsy Type 2:
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): 1 of Neurologist;Sleep Disorders Specialist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Neurology: Narcolepsy:
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Specialist Required: Yes
    Medical Test Required: Yes
    Specialist Type(s): 1 of Neurologist;Sleep Disorders Specialist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Number of Episodes of Cataplexy Required in Policy: N/A
    Documented Duration of Daily EDS Occurrences: N/A
    Policy Criteria Required to Document Patient Multiple Sleep Latency Test (MSLT): 1 of MSLT =< 8 min with evidence of >=2 SOREMPs;MSLT with evidence of 1 SOREMP, 15 min from preceding night polysomnography (PSG)
    Other causes of sleepiness have been ruled out.: No
    Patient must have CSF hypocretin 1 deficiency: Yes
    Patient Does Not Have a Deficiency of Succinic Semialdehyde Dehydrogenase: No
    Patient Does Not Have a History of Substance Abuse: No
    Patient is Not Using a Sedative Hypnotic: No
    Patient Will Not Be Using with Alcohol: No
    Documentation Requiring Patient to be Enrolled in REMS Success Program: No
    Documentation of prescriber enrollment in REMS program: No
    Prescriber Must Check Patient's Drug History on Controlled Substance Database: No
    Documented Time Period or Frequency of Time That the Precriber Must Regularly See the Patient: N/A
    Diagnosis Type(s): 1 of Excessive daytime sleepiness associated with narcolepsy;Narcolepsy Type 1 (with Cataplexy)
    Supporting Documentation Requirements: 2 of Chart Notes;Medication History;Polysomnography
    Documented Diagnosis: Yes
    Patient has >1 Cataplexy Episodes: No
    Documented Daily EDS occurrences >= 3 months: No
    MSLT <8min with evidence of 2 SOREMP's: No
    MSLT with evidence of >= 1 SOREMP's and SOREMP, 15 min from preceeding night PSG: No
    CSF Hypocretin-1 Deficiency: Yes
    Prescriber Must See Patient Every 3 Months: No